{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:29:17Z","timestamp":1783722557415,"version":"3.55.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T00:00:00Z","timestamp":1392336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088983","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T17:13:21Z","timestamp":1392398001000},"page":"e88983","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Wenle","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gooden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Soderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Toone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne F.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Walder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil L.","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583500005242","article-title":"The reaction of the psoralens with deoxyribonucleic acid","volume":"17","author":"JE Hearst","year":"1984","journal-title":"Q Rev Biophys"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1146\/annurev.bi.54.070185.005443","article-title":"Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry","volume":"54","author":"GD Cimino","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM197412052912301","article-title":"Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light","volume":"291","author":"JA Parrish","year":"1974","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.1985.tb11800.x","article-title":"Comparison of synthetic psoralen derivatives and 8-MOP in the inhibition of lymphocyte proliferation","volume":"453","author":"CL Berger","year":"1985","journal-title":"Ann N Y Acad Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous Tcell lymphoma by extracorporeal photochemotherapy. Preliminary results","volume":"316","author":"RL Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V92.9.3098","article-title":"Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease","volume":"92","author":"HT Greinix","year":"1998","journal-title":"Blood"},{"key":"ref7","first-page":"6158","article-title":"A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA. Proc Natl Acad Sci US","volume":"82","author":"JD Laskin","year":"1985"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0014-5793(02)02926-5","article-title":"PUVA-induced apoptosis involves mitochondrial dysfunction caused by the opening of the permeability transition pore","volume":"522","author":"M Canton","year":"2002","journal-title":"FEBS Letters"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)09702-0","article-title":"Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen\/ultraviolet light treatment","volume":"36","author":"HF Mermelstein","year":"1989","journal-title":"Mol Pharmacology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"DJ Slamon","year":"1987","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"DJ Slamon","year":"1989","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrclinonc.2009.234","article-title":"Management of breast cancer with targeted agents: importance of heterogeneity","volume":"7","author":"S Di Cosimo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"CE Geyer","year":"2006","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1200\/JCO.2007.13.9949","article-title":"Targeting HER2 in advanced inflammatory breast cancer with lapatinib monotherapy: A phase II study with biomarker profiles that predict for response","volume":"26","author":"S Johnston","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncponc0509","article-title":"Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer","volume":"3","author":"R Nahta","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/bcr3480","article-title":"An heregulin- EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models","volume":"15","author":"W Xia","year":"2013","journal-title":"Breast Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1535-7163.MCT-10-0991","article-title":"Truncated ErbB2 Expressed in Tumor Cell Nuclei Contributes to Acquired Therapeutic Resistance to ErbB2 Kinase Inhibitors","volume":"10","author":"W Xia","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1073\/pnas.0602468103","article-title":"A model of acquired autoresistance to ErbB2 tyrosine kinase inhibitors and a therapeutic strategy to prevent its onset in breast cancer","volume":"103","author":"W Xia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/0008-5472.CAN-03-2868","article-title":"Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase","volume":"264","author":"SK Rabindran","year":"2004","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1038\/sj.emboj.7601191","article-title":"Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation","volume":"25","author":"J Anido","year":"2006","journal-title":"EMBO J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nchembio.1212","article-title":"ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system","volume":"9","author":"S Polier","year":"2013","journal-title":"Nat Chem Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","article-title":"Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein","volume":"286","author":"C Aertgeerts","year":"2011","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1038\/sj.onc.1208774","article-title":"Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2 overexpressing breast cancer cells","volume":"24","author":"W Xia","year":"2005","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/0008-5472.CAN-08-2546","article-title":"Histone Deacetylase Inhibitor Sodium Butyrate Enhances the Cell Killing Effect of Psoralen plus UVA by Attenuating Nucleotide Excision Repair","volume":"69","author":"T Toyooka","year":"2009","journal-title":"Cancer Res"},{"key":"ref25","first-page":"1113","article-title":"Sensitization of breast cancer cells to radiation by trastuzumab","volume":"2","author":"K Liang","year":"2003","journal-title":"Mol Cancer Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T17:22:08Z","timestamp":1746120128000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088983"}},"subtitle":[],"editor":[{"given":"Jin Q.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088983","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718281452.793491208","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,14]]}}}